Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2023-12-11 00:00:00 ET · period of report 2023-12-07 · accession 0001415889-23-016183 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-12-11 | 2023-12-07 | KNSA | Paolini John F. | Chief MEDICAL Off | S - Sale+OE | $17.65 | -28.6K | 66.1K | -30% | -$504.8K |
| D | 2023-12-11 | 2023-12-07 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $1.86 | +28.6K | 73.5K | +64% | +$53.2K |
| D | 2023-12-11 | 2023-12-07 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $0.00 | -28.6K | 111.2K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2023-12-07 | S | D | 13,017 | $17.64 | 53,095 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.60 to $17.695. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 2 | Common | Class A Common Share | 2023-12-07 | S | D | 6,702 | $17.75 | 46,393 | D | — | — | (F4) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.70 to $17.795. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Common | Class A Common Share | 2023-12-07 | S | D | 1,501 | $17.81 | 44,892 | D | — | — | (F5) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.80 to $17.82. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 4 | Common | Class A Common Share | 2023-12-07 | M | A | 28,600 | $1.86 | 73,492 | D | — | — | |
| 5 | Common | Class A Common Share | 2023-12-07 | S | D | 7,380 | $17.54 | 66,112 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.50 to $17.595. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 6 | Derivative | Share Option | 2023-12-07 | M | D | 28,600 | $0.00 | 111,217 | D | $1.86 · — to 2026-09-13 | 28,600 Class A Common Shares | (F6) The option is fully vested and exercisable. |